NCT00842699已完成不适用
Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- The primary outcome is to look for expansion of regulatory T cells at one year.
研究概览
简要总结
The goal of the study is to find out the effects of two different drugs used at the beginning of organ transplantation on different populations of immune cells in the body of patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •all patients considered for transplantation
排除标准
- 未提供
结局指标
主要结局
The primary outcome is to look for expansion of regulatory T cells at one year.
时间窗: 12 months
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME)Kidney FailureNCT01595984Centre Hospitalier Universitaire, Amiens88
已完成
不适用
Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy SpecimensRenal Cell CarcinomaNCT00718367National University Hospital, Singapore
已完成
3 期
To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.Kidney TransplantationNCT00296361Astellas Pharma Inc634
已完成
1 期
PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal FunctionHealthyNCT02775955Pharmaceutical Project Solutions, Inc.24
已完成
3 期
Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose RegimenKidney TransplantationNCT00514514Novartis Pharmaceuticals802